HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juliano Ferreira Selected Research

Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)

8/2021Periorbital Nociception in a Progressive Multiple Sclerosis Mouse Model Is Dependent on TRPA1 Channel Activation.
5/2020Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juliano Ferreira Research Topics

Disease

65Pain (Aches)
04/2024 - 07/2000
56Hyperalgesia
04/2024 - 10/2002
30Neuralgia (Stump Neuralgia)
05/2020 - 10/2002
23Inflammation (Inflammations)
12/2022 - 07/2000
21Edema (Dropsy)
12/2022 - 08/2006
12Hypersensitivity (Allergy)
08/2021 - 08/2013
10Chronic Pain
01/2021 - 10/2002
9Neoplasms (Cancer)
04/2024 - 09/2013
8Cancer Pain
04/2024 - 09/2013
8Gout
12/2022 - 08/2011
8Seizures (Absence Seizure)
12/2013 - 12/2007
7Postoperative Pain
08/2023 - 11/2008
7Arthritis (Polyarthritis)
01/2020 - 08/2009
6Acute Pain
12/2017 - 04/2009
4Melanoma (Melanoma, Malignant)
08/2021 - 01/2016
4Tardive Dyskinesia
10/2014 - 07/2005
3Migraine Disorders (Migraine)
08/2023 - 01/2018
3Neuroinflammatory Diseases
01/2021 - 12/2017
3Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 12/2013
3Constipation
12/2020 - 10/2013
3Ischemia
01/2020 - 11/2011
3Contact Dermatitis (Eczema, Contact)
09/2019 - 01/2019
3Wounds and Injuries (Trauma)
12/2017 - 05/2014
3Surgical Wound
11/2017 - 11/2008
3Dyskinesias (Dyskinesia)
10/2014 - 07/2005
3Traumatic Brain Injuries (Traumatic Brain Injury)
05/2014 - 11/2011
3Cognitive Dysfunction
11/2013 - 01/2013
3Glutaric Acidemia I
02/2011 - 12/2007
3Metabolic Diseases (Metabolic Disease)
02/2011 - 12/2007
2Arthralgia (Joint Pain)
12/2022 - 07/2014
2Multiple Sclerosis
08/2021 - 05/2020
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
08/2021 - 05/2020

Drug/Important Bio-Agent (IBA)

18Analgesics (Analgesic Drugs)IBA
04/2024 - 08/2004
18Freund's AdjuvantIBA
05/2020 - 10/2002
16Capsaicin (Zostrix)FDA Link
01/2021 - 01/2003
14AnkyrinsIBA
08/2021 - 08/2013
11Opioid Analgesics (Opioids)IBA
04/2024 - 08/2004
11Peptides (Polypeptides)IBA
01/2021 - 10/2011
10Morphine (MS Contin)FDA LinkGeneric
04/2024 - 01/2003
10KininsIBA
06/2023 - 07/2000
9Calcium Channels (Calcium Channel)IBA
04/2024 - 01/2013
9AntioxidantsIBA
01/2021 - 12/2007
7Uric Acid (Urate)IBA
12/2022 - 08/2011
7VenomsIBA
01/2016 - 03/2007
6CalciumIBA
08/2023 - 01/2003
6Peroxidase (Myeloperoxidase)IBA
12/2022 - 12/2006
6EnzymesIBA
01/2021 - 12/2006
6Thioctic Acid (Lipoic Acid)IBA
01/2021 - 01/2016
6Paclitaxel (Taxol)FDA LinkGeneric
12/2020 - 12/2013
62- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA
05/2020 - 06/2011
6CarrageenanIBA
07/2014 - 04/2006
5Conotoxins (Conotoxin)IBA
01/2021 - 01/2013
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2020 - 11/2008
5Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2019 - 11/2013
5Adenosine Triphosphatases (ATPase)IBA
02/2016 - 12/2007
5ProstaglandinsIBA
02/2012 - 08/2006
4icatibantIBA
06/2023 - 12/2002
4CytokinesIBA
01/2022 - 03/2010
4acetovanillone (apocynin)IBA
05/2020 - 11/2013
4N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA
01/2020 - 08/2006
4Irritants (Vesicants)IBA
09/2019 - 08/2013
4Dexamethasone (Maxidex)FDA LinkGeneric
03/2019 - 08/2004
4Celecoxib (Celebrex)FDA Link
09/2014 - 08/2004
4glutaric acidIBA
01/2013 - 12/2007
32- ((3- (1,3- benzodioxol- 5- yl)- 3- (((6- methoxy- 2- naphthyl)sulfonyl)amino)propanoyl)amino)- 3- (4- ((2,6- dimethylpiperidinyl)methyl)phenyl)- N- isopropyl- N- methylpropanamideIBA
06/2023 - 10/2011
3FR 173657IBA
06/2023 - 10/2011
3TRPA1 Cation ChannelIBA
08/2021 - 01/2016
3Methadone (Dolophine)FDA LinkGeneric
08/2021 - 10/2013
3Antisense OligonucleotidesIBA
05/2020 - 01/2019
3TRPV1 receptorIBA
01/2020 - 02/2011
3cinnamaldehyde (cinnamic aldehyde)FDA Link
03/2019 - 06/2011
3Complex MixturesIBA
03/2019 - 01/2013
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 04/2009
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2017 - 01/2016
3Formaldehyde (Formol)FDA Link
07/2017 - 01/2003
3KetamineFDA LinkGeneric
01/2017 - 08/2004
3InterleukinsIBA
01/2016 - 06/2013
3salicylhydroxamic acid (SHAM)IBA
01/2016 - 09/2012
3Haloperidol (Haldol)FDA LinkGeneric
10/2014 - 07/2005
3Antipsychotic Agents (Antipsychotics)IBA
10/2014 - 10/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014 - 03/2010
3BradykininIBA
05/2014 - 12/2002
3Serotonin (5 Hydroxytryptamine)IBA
04/2014 - 08/2011
3Monoamine Oxidase (MAO)IBA
11/2013 - 09/2012
3Dinoprostone (PGE2)FDA Link
06/2013 - 08/2006
3TriterpenesIBA
04/2013 - 10/2002
2R-Type Calcium Channels (R-Type Calcium Channel)IBA
08/2023 - 10/2011
2Calcitonin Gene-Related PeptideIBA
01/2022 - 08/2006
2Ion Channels (Ion Channel)IBA
08/2021 - 01/2020

Therapy/Procedure

12Ligation
12/2017 - 10/2002
9Therapeutics
12/2020 - 12/2011
8Analgesia
08/2023 - 04/2005
7Oral Administration
12/2017 - 10/2002
5Drug Therapy (Chemotherapy)
01/2021 - 12/2017
4Spinal Injections
04/2020 - 10/2011
4Traditional Medicine (Folk Remedies)
10/2013 - 08/2008
3Intra-Articular Injections
01/2020 - 06/2013
3Aftercare (After-Treatment)
01/2017 - 09/2012
3Subcutaneous Injections
05/2014 - 08/2011
2Injections
12/2022 - 07/2017